Home / Cancer treatment in China / Breast cancer treatment / How curable it is
Prognosis, with the denominator
How Curable Is Breast Cancer?
There is no single answer to how curable breast cancer is. Many people with invasive cancer that has not spread outside the breast are alive five years later, and metastatic disease is much harder to survive. The American Cancer Society, using SEER, reports 5-year relative survival of greater than 99% for localized invasive disease, 87% for regional, 32% for distant, and 92% overall, for women diagnosed from 2015 through 2021. Those figures are not a personal prediction and not a hospital score.
Applicability: the number belongs to the stage at first diagnosis. It does not update itself if the cancer later spreads, and it does not include DCIS in the localized row.
Relative survivalWomen, 2015–2021Not a promise
What the figures measure
| SEER group at diagnosis | 5-year relative survival | Plain meaning |
|---|---|---|
| Localized invasive cancer | Greater than 99% | No sign of spread outside the breast. DCIS is excluded from this row. |
| Regional | 87% | Spread to nearby structures or lymph nodes. |
| Distant | 32% | Spread to distant organs such as lung, liver, or bone. |
| All SEER stages | 92% | The mix of those groups, not a typical metastatic case. |
Source: American Cancer Society page using SEER, for women diagnosed 2015–2021. SEER groups are not the same labels as AJCC stage I, II, III, and IV. Relative survival compares people with cancer with similar people without it. It is not the percentage a clinic “cures.”
Why a cure claim would be false
Localized disease and distant disease do not share an outlook. Subtype also changes risk, which is why this page does not collapse HR-positive, HER2-positive, and triple-negative cancer into one curability sentence. NCI describes metastatic treatment as care that slows spread and controls symptoms, not as a universal cure. “Cancer cure discovered” is not a factual description of these data.
The figures also do not say what will happen to one person. Age, other illnesses, grade, receptors, HER2, and how the cancer responded to treatment sit outside a three-row table.
What this site will not invent
No survival rate is given for a named hospital, a city, or a package. No China-versus-US comparison is made. Screening can find cancer earlier; that is a CDC point about stage, not a claim that every screened cancer is cured.
When a case review may help
A review cannot calculate a personal cure probability. It can stop a quote that uses “curable” without saying localized, regional, or distant, and without the receptor results. The stage page is the companion explanation.
In this cluster
- Breast cancer treatment
- Treatment by stage
- Latest treatment
- How curable it is (this page)
- Immunotherapy
- Treatment in China
Questions people ask
Is breast cancer deadly?
It can be. The same SEER table shows a 32% 5-year relative survival for distant disease and a much higher figure when invasive cancer is still localized. The word “deadly” without the stage is not a useful medical statement.
Do these numbers include DCIS?
The localized row is invasive cancer only. The American Cancer Society says it does not include ductal carcinoma in situ.
Can a hospital advertise a cure rate from this table?
No. The table is a US population figure for women diagnosed in 2015–2021. It is not a hospital outcome.
Sources
- American Cancer Society, Survival Rates for Breast Cancer. SEER 5-year relative survival for women diagnosed 2015–2021. Page retrieved 3 October 2026.
- NCI, Breast Cancer Treatment by Stage. Metastatic treatment is described as slowing spread and controlling symptoms.
Evidence check: 3 October 2026. US approvals are not proof that a hospital in China stocks the drug or will accept an international patient.
Review a prognosis question without a personal prediction
Population survival figures are not a personal cure probability and not a hospital score. ParkMega does not calculate either.